Login
Member Login
Member Login
About
About SMI
Board of Directors
SMI Staff
FAQs
SMI Antitrust Guidelines
Membership
About Membership
Member Eligibility
SMI Community
Tools
SMI Toolbox
Programs
About Programs
Advocacy Program
Advancing Women Leaders (AWL)
Tom Hughes Collaboration Award
Councils
About Councils
Clinical Integration
Key Strategic Collaboration
Supply Chain Community Impact
Intelligent Supply Chain
Events & Media
Events
Podcast
Press Releases
Clinical Integration Maturity Model – Trading Partner, together (selection 5)
Step
1
of
4
25%
Step 2:
Together Provider and Industry Partner
Provider Individually
Provider Organization
Industry Partner
Industry Partner Organization
Step 3:
From the options below, which level best represents your organization/service line/department/ OR program in facilitating patient care:
People - Providers
Level 4
Fully integrated and aligned incentives
Collaborative decision making between SC and MDs/ Nursing leaders/ Finance for product purchase, procedures and care pathways. Program based, agile partnership between SC and MDs on clinical & economic evidence, performance metrics and tracking.
Level 3
Cross functional understanding of stakeholder needs and requirements. System-wide clinical integration if applicable
Physicians/Clinicians engaged in decision making from the planning stages. Service line focused approach with emphasis on performance metrics on tracking.
Level 2
Common language and communications
Physicians/Clinicians engaged in supply chain decisions near the end of a decision (for a category or contract). Physician/Clinician preferences acknowledged.
Level 1
Beginning the Conversation
Limited/ no connectivity between Supply Chain and physicians/clinicians. Physicians/Clinicians preferences rarely acknowledged for contracts. Main emphasis is on cost of the device/ equipment rather than clinical evidence, supply reliability & forecasting plans.
People - Industry Partners
Level 4
Fully integrated and aligned incentives
Creating accountable small group of commercial & clinical leaders to have focused meetings with SC/MD leaders of the IDN to drive mutual value for both the organizations.
Level 3
Cross functional understanding of stakeholder needs and requirements. System-wide clinical integration if applicable
Suppliers aligned with providers from some type of risk component.
Level 2
Common language and communications
Suppliers share retrospective data; contracts based on spend alone.
Level 1
Beginning the Conversation
Reactive approach to supply management (e.g., need more inventory because demand planning data is not available). No risk sharing contracts, no tracking of usage performance
Step 4:
From the options below, which level best represents your organization/service line/department/ OR program in facilitating patient care:
Process - Providers
Level 4
Fully integrated and aligned incentives
Governance structure (including supply chain, Physician/Clinician and Finance leaders) in place to analyze the data and make it actionable for the hospital system. Contract Compliance is actively monitored to drive maximum value for provider. Product decisions are proactive and strategic to drive quality, value and standardization. (Process to monitor compliance for collaborative decisions of purchase).
Level 3
Cross functional understanding of stakeholder needs and requirements. System-wide clinical integration if applicable
Strong value analysis program established where clinical evidence is in use in many cases. Physicians are on the committees / are engaged but not completely aligned.
Level 2
Common language and communications
IDN has limited value analysis program led by supply chain. Product decisions are made with limited or no physician engagement. Purchases mainly based on demand.
Level 1
Beginning the Conversation
Process workflows not clearly defined for driving clinical Efficiency. IDN has no or limited value analysis program. Product decisions are made without physician/clinician engagement, based on short term demands only.
Process - Industry Partners
Level 4
Fully integrated and aligned incentives
Regular cadence of business review meetings with SC and MD leaders to understand IDN priorities and jointly discuss commercial and clinical models. Partners in business model innovation (BMI) to look beyond price and drive meaningful growth & achive contract compliance. Definded processes for clinical and commercial partnerships (e.g. outcomes protection programs/Value based programs), Executive engagement as nedded.
Level 3
Cross functional understanding of stakeholder needs and requirements. Clinical integration across company divisions
Some risk share arrangements may be in place; alignment with provider and physicians on product decisions and efficiencies (e.g., block schedules).
Level 2
Common language and communications
No/limited risk share agreements. Siloed approach in contraction with the providers for supplies / equipment. Some data available for demand planning from the provider (may be provided by provider or collected based on purchase history).
Level 1
Beginning the Conversation
Limited or no understanding of capital planning and supply forecasting across IDN. No risk sharing/ outcomes protection agreements. Only transactional approach in supplying products as per the provider demands.
Step 5:
From the options below, which level best represents your organization/service line/department/ OR program in facilitating patient care:
Technology - Providers
Level 4
Fully integrated and aligned incentives
Transparent data analysis, use of automation/ AI to drive accountability and compliance. Interoperability between SC and EMR syses for better utilization tracking and forecasting.
Level 3
Cross functional understanding of stakeholder needs and requirements. System-wide clinical integration if applicable
SC and EMR platforms connected but may not drive decisions-making or provide actionable insights & foreasting. SUpply usage is available and ties in with quality and outcomers - may rquire interfaces or manial manipulation.
Level 2
Common language and communications
Some visibility to SC via EMR or reporting but not readily available or is manual. Limited interfaces or integrations.
Level 1
Beginning the Conversation
No integration between Supply Chain and EMR systems to assess and predict forecasting of devices/equipment across IDN.
Technology - Industry Partners
Level 4
Fully integrated and aligned incentives
Full data visibility for current device / equipment analysis and future demand planning across IDN. Recommendations to the IDN for adoption of tech to drive growth, efficiency & outcomes.
Level 3
Cross functional understanding of stakeholder needs and requirements. Clinical integration across company divisions
Fragmented visibility of device/ equipment analysis data for future planning across IDN to drive growth, efficiency and outcomes.
Level 2
Common language and communications
Technology is internal focused but there may be applications to support a more strategic approach (e.g., some quality data) to improve provider efficiency and suggest growth opportunities.
Level 1
Beginning the Conversation
No visibility to device/ equipment analysis data for medium to long term planning across IDN to drive growth and efficiency. No usage of market scan reports for growth opportunity suggestions.
Email
This field is for validation purposes and should be left unchanged.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
OK
Privacy Policy
